Teva Pharmaceutical Industries (TEVA) shares were up 5.2% in recent trading on Monday after JPMorgan Upgrades rating to overweight from neutral.
The firm raised its price target on the company's stock to $23 from $21.
Trading volume stood at about 12.7 million shares against a daily average of 12.6 million.
Price: 17.83, Change: +0.90, Percent Change: +5.32